|
1
|
Mozaffarian D, Benjamin EJ, Go AS, et al:
Heart disease and stroke statistics-2015 update: A report from the
american heart association. Circulation. 131:e29–e322. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stefanini GG and Holmes DR Jr:
Drug-eluting coronary-artery stents. N Engl J Med. 368:254–265.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Donnan GA, Fisher M, Macleod M and Davis
SM: Stroke. Lancet. 371:1612–1623. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Arnett DK, Baird AE, Barkley RA, et al:
American Heart Association Council on Epidemiology and Prevention;
American Heart Association Stroke Council; Functional Genomics and
Translational Biology Interdisciplinary Working Group: Relevance of
genetics and genomics for prevention and treatment of
cardiovascular disease: A scientific statement from the American
Heart Association Council on Epidemiology and Prevention, the
Stroke Council and the Functional Genomics and Translational
Biology Interdisciplinary Working Group. Circulation.
115:2878–2901. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Roberts R and Stewart AF: The genetics of
coronary artery disease. Curr Opin Cardiol. 27:221–227. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hassan A and Markus HS: Genetics and
ischaemic stroke. Brain. 123:1784–1812. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dichgans M: Genetics of ischaemic stroke.
Lancet Neurol. 6:149–161. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Banerjee A, Lim CC, Silver LE, Welch SJ,
Banning AP and Rothwell PM: Familial history of stroke is
associated with acute coronary syndromes in women. Circ Cardiovasc
Genet. 4:9–15. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wellcome Trust Case Control Consortium:
Genome-wide association study of 14,000 cases of seven common
diseases and 3,000 shared controls. Nature. 447:661–678. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Helgadottir A, Thorleifsson G, Manolescu
A, et al: A common variant on chromosome 9p21 affects the risk of
myocardial infarction. Science. 316:1491–1493. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
McPherson R, Pertsemlidis A, Kavaslar N,
et al: A common allele on chromosome 9 associated with coronary
heart disease. Science. 316:1488–1491. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Samani NJ, Erdmann J, Hall AS, et al:
WTCCC and the Cardiogenics Consortium: Genomewide association
analysis of coronary artery disease. N Engl J Med. 357:443–453.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Peden JF, Hopewell JC, Saleheen D, et al:
Coronary Artery Disease (C4D) Genetics Consortium: A genome-wide
association study in Europeans and South Asians identifies five new
loci for coronary artery disease. Nat Genet. 43:339–344. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schunkert H, König IR, Kathiresan S, et
al: Cardiogenics; CARDIoGRAM Consortium: Large-scale association
analysis identifies 13 new susceptibility loci for coronary artery
disease. Nat Genet. 43:333–338. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Deloukas P, Kanoni S, Willenborg C, et al:
CARDIoGRAMplusC4D Consortium; DIAGRAM Consortium; CARDIOGENICS
Consortium; MuTHER Consortium; Wellcome Trust Case Control
Consortium: Large-scale association analysis identifies new risk
loci for coronary artery disease. Nat Genet. 45:25–33. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gretarsdottir S, Thorleifsson G, Manolescu
A, et al: Risk variants for atrial fibrillation on chromosome 4q25
associate with ischemic stroke. Ann Neurol. 64:402–409. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ikram MA, Seshadri S, Bis JC, et al:
Genomewide association studies of stroke. N Engl J Med.
360:1718–1728. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gudbjartsson DF, Holm H, Gretarsdottir S,
et al: A sequence variant in ZFHX3 on 16q22 associates with atrial
fibrillation and ischemic stroke. Nat Genet. 41:876–878. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bellenguez C, Bevan S, Gschwendtner A, et
al: International Stroke Genetics Consortium (ISGC); Wellcome Trust
Case Control Consortium 2 (WTCCC2): Genome-wide association study
identifies a variant in HDAC9 associated with large vessel ischemic
stroke. Nat Genet. 44:328–333. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Traylor M, Farrall M, Holliday EG, et al:
Australian Stroke Genetics Collaborative, Wellcome Trust Case
Control Consortium 2 (WTCCC2); International Stroke Genetics
Consortium: Genetic risk factors for ischaemic stroke and its
subtypes (the METASTROKE collaboration): A meta-analysis of
genome-wide association studies. Lancet Neurol. 11:951–962. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kilarski LL, Achterberg S, Devan WJ, et
al: GARNET Collaborative Research Group, Wellcome Trust Case
Control Consortium 2, Australian Stroke Genetic Collaborative, the
METASTROKE Consortium, and the International Stroke Genetics
Consortium: Meta-analysis in more than 17,900 cases of ischemic
stroke reveals a novel association at 12q24.12. Neurology.
83:678–685. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gschwendtner A, Bevan S, Cole JW, et al:
International Stroke Genetics Consortium: Sequence variants on
chromosome 9p21.3 confer risk for atherosclerotic stroke. Ann
Neurol. 65:531–539. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Williams FM, Carter AM, Hysi PG, et al:
EuroCLOT Investigators; Wellcome Trust Case Control Consortium 2;
MOnica Risk, Genetics, Archiving and Monograph; MetaStroke;
International Stroke Genetics Consortium: Ischemic stroke is
associated with the ABO locus: The EuroCLOT study. Ann Neurol.
73:16–31. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dichgans M, Malik R, König IR, et al:
METASTROKE Consortium; CARDIoGRAM Consortium; C4D Consortium;
International Stroke Genetics Consortium: Shared genetic
susceptibility to ischemic stroke and coronary artery disease: A
genome-wide analysis of common variants. Stroke. 45:24–36. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yamada Y, Nishida T, Ichihara S, et al:
Association of a polymorphism of BTN2A1 with myocardial infarction
in East Asian populations. Atherosclerosis. 215:145–152. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yamada Y, Fuku N, Tanaka M, et al:
Identification of CELSR1 as a susceptibility gene for ischemic
stroke in Japanese individuals by a genome-wide association study.
Atherosclerosis. 207:144–149. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yamada Y, Nishida T, Ichihara S, et al:
Identification of chromosome 3q28 and ALPK1 as susceptibility loci
for chronic kidney disease in Japanese individuals by a genome-wide
association study. J Med Genet. 50:410–418. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yamada Y, Matsuo H, Segawa T, et al:
Assessment of genetic risk for myocardial infarction. Thromb
Haemost. 96:220–227. 2006.PubMed/NCBI
|
|
29
|
Fujimaki T, Kato K, Yoshida T, et al:
Association of genetic variants with myocardial infarction in
Japanese individuals with chronic kidney disease. Thromb Haemost.
101:963–968. 2009.PubMed/NCBI
|
|
30
|
Oguri M, Kato K, Yokoi K, et al:
Association of genetic variants with myocardial infarction in
Japanese individuals with metabolic syndrome. Atherosclerosis.
206:486–493. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yamada Y, Matsui K, Takeuchi I, Oguri M
and Fujimaki T: Association of genetic variants with hypertension
in a longitudinal population-based genetic epidemiological study.
Int J Mol Med. (In press).
|
|
32
|
Shimokata S, Oguri M, Fujimaki T, Horibe
H, Kato K and Yamada Y: Association between polymorphisms of the
α-kinase 1 gene and type 2 diabetes mellitus in community-dwelling
individuals. Biomed Rep. 1:940–944. 2013.PubMed/NCBI
|
|
33
|
Ueyama C, Horibe H, Fujimaki T, Oguri M,
Kato K and Yamada Y: Association of genetic variants of CELSR1 and
3q28 with hypertension in community-dwelling individuals. Biomed
Rep. 1:840–844. 2013.PubMed/NCBI
|
|
34
|
Oguri M, Fujimaki T, Horibe H, Kato K,
Ichihara S and Yamada Y: Association of a polymorphism of BTN2A1
with chronic kidney disease in community-dwelling individuals.
Biomed Rep. 1:868–872. 2013.PubMed/NCBI
|
|
35
|
Fujimaki T, Horibe H, Oguri M, Kato K and
Yamada Y: Association of genetic variants of the α-kinase 1 gene
with myocardial infarction in community-dwelling individuals.
Biomed Rep. 2:127–131. 2014.PubMed/NCBI
|
|
36
|
Horibe H, Ueyama C, Fujimaki T, Oguri M,
Kato K, Ichihara S and Yamada Y: Association of a polymorphism of
BTN2A1 with dyslipidemia in community-dwelling individuals. Mol Med
Rep. 9:808–812. 2014.PubMed/NCBI
|
|
37
|
Murakata Y, Fujimaki T and Yamada Y:
Association of a butyrophilin, subfamily 2, member A1 gene
polymorphism with hypertension. Biomed Rep. 2:818–822.
2014.PubMed/NCBI
|
|
38
|
Itoh Y, Mizuki N, Shimada T, Azuma F,
Itakura M, Kashiwase K, Kikkawa E, Kulski JK, Satake M and Inoko H:
High-throughput DNA typing of HLA-A, -B, -C and -DRB1 loci by a
PCR-SSOP-Luminex method in the Japanese population. Immunogenetics.
57:717–729. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gibbons RD, Hedeker D and DuToit S:
Advances in analysis of longitudinal data. Annu Rev Clin Psychol.
6:79–107. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Heine M, Cramm-Behrens CI, Ansari A, Chu
HP, Ryazanov AG, Naim HY and Jacob R: α-kinase 1, a new component
in apical protein transport. J Biol Chem. 280:25637–25643. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wang SJ, Tu HP, Ko AM, Chiang SL, Chiou
SJ, Lee SS, Tsai YS, Lee CP and Ko YC: Lymphocyte α-kinase is a
gout-susceptible gene involved in monosodium urate
monohydrate-induced inflammatory responses. J Mol Med Berl.
89:1241–1251. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Newman DJ, Thakkar H, Edwards RG, Wilkie
M, White T, Grubb AO and Price CP: Serum cystatin C measured by
automated immunoassay: A more sensitive marker of changes in GFR
than serum creatinine. Kidney Int. 47:312–318. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Singh D, Whooley MA, Ix JH, Ali S and
Shlipak MG: Association of cystatin C and estimated GFR with
inflammatory biomarkers: The Heart and Soul Study. Nephrol Dial
Transplant. 22:1087–1092. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Shlipak MG, Katz R, Cushman M, Sarnak MJ,
Stehman-Breen C, Psaty BM, Siscovick D, Tracy RP, Newman A and
Fried L: Cystatin-C and inflammatory markers in the ambulatory
elderly. Am J Med. 118:14162005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang GN, Sun K, Hu DL, Wu HH, Wang XZ and
Zhang JS: Serum cystatin C levels are associated with coronary
artery disease and its severity. Clin Biochem. 47:176–181. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Dandana A, Gammoudi I, Chalghoum A, Chahed
H, Addad F, Ferchichi S and Miled A: Clinical utility of serum
cystatin C in predicting coronary artery disease in patients
without chronic kidney disease. J Clin Lab Anal. 28:191–197. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Qing X, Furong W, Yunxia L, Jian Z, Xuping
W and Ling G: Cystatin C and asymptomatic coronary artery disease
in patients with metabolic syndrome and normal glomerular
filtration rate. Cardiovasc Diabetol. 11:1082012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Patel D, Ahmad S, Silverman A and Lindsay
J: Effect of cystatin C levels on angiographic atherosclerosis
progression and events among postmenopausal women with
angiographically decompensated coronary artery disease (from the
Women's Angiographic Vitamin and Estrogen [WAVE] study). Am J
Cardiol. 111:1681–1687. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Koenig W, Twardella D, Brenner H and
Rothenbacher D: Plasma concentrations of cystatin C in patients
with coronary heart disease and risk for secondary cardiovascular
events: More than simply a marker of glomerular filtration rate.
Clin Chem. 51:321–327. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Woitas RP, Kleber ME, Meinitzer A, et al:
Cystatin C is independently associated with total and
cardiovascular mortality in individuals undergoing coronary
angiography. The Ludwigshafen Risk and Cardiovascular Health
(LURIC) study. Atherosclerosis. 229:541–548. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ni L, Lü J, Hou LB, Yan JT, Fan Q, Hui R,
Cianflone K, Wang W and Wang DW: Cystatin C, associated with
hemorrhagic and ischemic stroke, is a strong predictor of the risk
of cardiovascular events and death in Chinese. Stroke.
38:3287–3288. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Seliger SL, Longstreth WT Jr, Katz R, et
al: Cystatin C and subclinical brain infarction. J Am Soc Nephrol.
16:3721–3727. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Stenina OI, Byzova TV, Adams JC, McCarthy
JJ, Topol EJ and Plow EF: Coronary artery disease and the
thrombospondin single nucleotide polymorphisms. Int J Biochem Cell
Biol. 36:1013–1030. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Majack RA, Goodman LV and Dixit VM: Cell
surface thrombospondin is functionally essential for vascular
smooth muscle cell proliferation. J Cell Biol. 106:415–422. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Kyriakides TR, Zhu YH, Smith LT, et al:
Mice that lack thrombospondin 2 display connective tissue
abnormalities that are associated with disordered collagen
fibrillogenesis, an increased vascular density, and a bleeding
diathesis. J Cell Biol. 140:419–430. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Yang Z, Kyriakides TR and Bornstein P:
Matricellular proteins as modulators of cell-matrix interactions:
Adhesive defect in thrombospondin 2-null fibroblasts is a
consequence of increased levels of matrix metalloproteinase-2. Mol
Biol Cell. 11:3353–3364. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Yang Z, Strickland DK and Bornstein P:
Extracellular matrix metalloproteinase 2 levels are regulated by
the low density lipoprotein-related scavenger receptor and
thrombospondin 2. J Biol Chem. 276:8403–8408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Topol EJ, McCarthy J, Gabriel S, et al:
Single nucleotide polymorphisms in multiple novel thrombospondin
genes may be associated with familial premature myocardial
infarction. Circulation. 104:2641–2644. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Boekholdt SM, Trip MD, Peters RJ, Engelen
M, Boer JM, Feskens EJ, Zwinderman AH, Kastelein JJ and Reitsma PH:
Thrombospondin-2 polymorphism is associated with a reduced risk of
premature myocardial infarction. Arterioscler Thromb Vasc Biol.
22:e24–e27. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Ehret GB, O'Connor AA, Weder A, Cooper RS
and Chakravarti A: Follow-up of a major linkage peak on chromosome
1 reveals suggestive QTLs associated with essential hypertension:
GenNet study. Eur J Hum Genet. 17:1650–1657. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Shriner D, Adeyemo A and Rotimi CN: Joint
ancestry and association testing in admixed individuals. PLoS
Comput Biol. 7:e10023252011. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Smith NL, Chen MH, Dehghan A, et al:
Wellcome Trust Case Control Consortium: Novel associations of
multiple genetic loci with plasma levels of factor VII, factor
VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and
Aging Research in Genome Epidemiology) Consortium. Circulation.
121:1382–1392. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Tang W, Schwienbacher C, Lopez LM, et al:
Genetic associations for activated partial thromboplastin time and
prothrombin time, their gene expression profiles, and risk of
coronary artery disease. Am J Hum Genet. 91:152–162. 2012.
View Article : Google Scholar : PubMed/NCBI
|
